Amalgamated Bank’s Ocular Therapeutix OCUL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $50K | Hold |
5,402
| – | – | ﹤0.01% | 1826 |
|
|
2025
Q1 | $40K | Buy |
5,402
+18
| +0.3% | +$133 | ﹤0.01% | 1841 |
|
|
2024
Q4 | $46K | Hold |
5,384
| – | – | ﹤0.01% | 1854 |
|
|
2024
Q3 | $47K | Hold |
5,384
| – | – | ﹤0.01% | 1867 |
|
|
2024
Q2 | $37K | Buy |
5,384
+1,481
| +38% | +$10.2K | ﹤0.01% | 1929 |
|
|
2024
Q1 | $36K | Sell |
3,903
-7,184
| -65% | -$66.3K | ﹤0.01% | 1945 |
|
|
2023
Q4 | $49K | Sell |
11,087
-794
| -7% | -$3.51K | ﹤0.01% | 2259 |
|
|
2023
Q3 | $37K | Hold |
11,881
| – | – | ﹤0.01% | 2379 |
|
|
2023
Q2 | $61K | Buy |
11,881
+1,137
| +11% | +$5.84K | ﹤0.01% | 2243 |
|
|
2023
Q1 | $57K | Sell |
10,744
-1,616
| -13% | -$8.57K | ﹤0.01% | 2259 |
|
|
2022
Q4 | $35K | Hold |
12,360
| – | – | ﹤0.01% | 2579 |
|
|
2022
Q3 | $51K | Buy |
12,360
+196
| +2% | +$809 | ﹤0.01% | 2451 |
|
|
2022
Q2 | $49K | Sell |
12,164
-355
| -3% | -$1.43K | ﹤0.01% | 2497 |
|
|
2022
Q1 | $62K | Sell |
12,519
-1,013
| -7% | -$5.02K | ﹤0.01% | 2370 |
|
|
2021
Q4 | $94K | Sell |
13,532
-253
| -2% | -$1.76K | ﹤0.01% | 2069 |
|
|
2021
Q3 | $138K | Sell |
13,785
-690
| -5% | -$6.91K | ﹤0.01% | 2047 |
|
|
2021
Q2 | $205K | Buy |
14,475
+4,203
| +41% | +$59.5K | ﹤0.01% | 2022 |
|
|
2021
Q1 | $169K | Sell |
10,272
-390
| -4% | -$6.42K | 0.01% | 1517 |
|
|
2020
Q4 | $221K | Buy |
+10,662
| New | +$221K | 0.01% | 1395 |
|